NR1H4 and inflammatory bowel disease: We believe our article can make a significant contribution to the literature because we not only decipher the changed gut microbiota composition in IBD, but focus on how this alteration can promote IBD by discussing the changed microbiota-derived metabolites and signaling pathway activity caused by receptors, such as TGR5, FXR, and AhR.